Cogentix Medical (NASDAQ: CGNT) reported Q4 EPS of ($0.15), $0.12 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $7 million versus the consensus estimate of $13 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.